Danish taskforce recommendations on life science welcomed

17 November 2025

Industry has welcomed the recommendations of the Danish government's Taskforce for enhanced knowledge and technology transfer.

The taskforce was tasked with coming up with recommendations to translate more ideas and research results into concrete solutions, entrepreneurship, companies and jobs. 

Anders Hoff, the political head of research and innovation at Lif, said: “It is an important step, because within life science we unfortunately see that the development of new innovative treatments is increasingly taking place in other parts of the world despite the fact that we actually have a really good research base in Denmark. The task force's recommendations therefore fall on dry ground.”

This article is accessible to registered users, to continue reading please register for free.  A free trial will give you access to exclusive features, interviews, round-ups and commentary from the sharpest minds in the pharmaceutical and biotechnology space for a week. If you are already a registered user please login. If your trial has come to an end, you can subscribe here.

Login to your account

Become a subscriber

 

£820

Or £77 per month

Subscribe Now
  • Unfettered access to industry-leading news, commentary and analysis in pharma and biotech.
  • Updates from clinical trials, conferences, M&A, licensing, financing, regulation, patents & legal, executive appointments, commercial strategy and financial results.
  • Daily roundup of key events in pharma and biotech.
  • Monthly in-depth briefings on Boardroom appointments and M&A news.
  • Choose from a cost-effective annual package or a flexible monthly subscription
The Pharma Letter is an extremely useful and valuable Life Sciences service that brings together a daily update on performance people and products. It’s part of the key information for keeping me informed

Chairman, Sanofi Aventis UK





Today's issue

Company Spotlight



More Features in Pharmaceutical